Estrogen + Levonorgestrel. Patch Suppliers & Bulk Manufacturers
Available Forms: Patch
Available Strengths: 50 μg estradiol + 10 mg levonorgestrel.
Reference Brands: Climara(EU & US)
Category:
Sexual Wellness
Estrogen + levonorgestrel patch delivers hormones through the skin, releasing estradiol and levonorgestrel to regulate menstrual cycles and prevent pregnancy. It alleviates menopausal symptoms like hot flashes, supports bone health, and provides effective contraception. Benefits include steady hormone levels, convenience, reduced side effects, and improved adherence.
Estrogen + levonorgestrel. patch is available in Patch
and strengths such as 50 μg estradiol + 10 mg levonorgestrel..
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Estrogen + levonorgestrel. patch is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Estrogen + levonorgestrel. patch can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Estrogen + levonorgestrel patches, such as Climara Pro and others, are approved in the US by the FDA and in the EU via EMA for menopausal hormone therapy and contraception. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, FDA reviews clinical trial and manufacturing data, while the EMA ensures compliance with regional safety and quality standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing